Conflict of interest
A. Dan, E. Bicakcic, G. Fabian, Z. Kahan, G. Penthedourakis, J. Sgouros, C. Thallinger and A. Wrona declare that they have no competing interests. L.N. Gales declares lecture fees from Actavis, Angelini, Amgen, AstraZeneca, Astellas, BMS, Boehringer, Bayer, Ipsen, J&J, Magnapharm, Merck, MSD, Novartis, Pfizer, Roche, Sanofi, Sandoz, and Servier. M. Mencinger declares honoraria/lecture fees from BMS, Janssen, Astellas, Roche, Pfizer, Sanofi, Amgen, Bausch Health, and Novartis. C.G. Kuhar declares honoraria/lecture fees from Roche, Pfizer, Novartis, Lilly, MSD, LEK, KRKA, Merck, Bayer, and BMS. D. Sirbu declares honoraria/lecture fees from BMS, Novartis, Pfizer, Roche, Ipsen, AstraZeneca, Sandoz, Lilly, Astellas, and Merck. U. Janzic declares honoraria/lecture fees from MSD, Pfizer, Roche, AstraZeneca, Boehringer Ingelheim, and Takeda. P. Berzinec declares grants from Roche; honoraria/fees from Amgen, Bayer, Roche, and Takeda; participation in a company sponsored speaker’s bureau from AstraZeneca, Boehringer Ingelheim, and MSD. M. Vosmik declares grants from BMS; honoraria/fees from BMS, MSD, Sanofi, Eli Lilly; participation in a company sponsored speaker’s bureau from BMS, MSD, and Sanofi. C. Zielinski declares honoraria/fees from Athenex, MSD, Imugene, AstraZeneca, Servier, and Eli Lilly. L. Simetic declares grants from MSD, Novartis, BMS, Genesis Pharma, and Roche; honoraria/fees from MSD, Novartis, BMS, Genesis Pharma, and Roche.